Literature DB >> 22784603

Multifunctional triblock copolymers for intracellular messenger RNA delivery.

Connie Cheng1, Anthony J Convertine, Patrick S Stayton, James D Bryers.   

Abstract

Messenger RNA (mRNA) is a promising alternative to plasmid DNA (pDNA) for gene vaccination applications, but safe and effective delivery systems are rare. Reversible addition-fragmentation chain transfer (RAFT) polymerization was employed to synthesize a series of triblock copolymers designed to enhance the intracellular delivery of mRNA. These materials are composed of a cationic dimethylaminoethyl methacrylate (DMAEMA) segment to mediate mRNA condensation, a hydrophilic poly(ethylene glycol) methyl ether methacrylate (PEGMA) segment to enhance stability and biocompatibility, and a pH-responsive endosomolytic copolymer of diethylaminoethyl methacrylate (DEAEMA) and butyl methacrylate (BMA) designed to facilitate cytosolic entry. The blocking order and PEGMA segment length were systematically varied to investigate the effect of different polymer architectures on mRNA delivery efficacy. These polymers were monodisperse, exhibited pH-dependent hemolytic activity, and condensed mRNA into 86-216 nm particles. mRNA polyplexes formed from polymers with the PEGMA segment in the center of the polymer chain displayed the greatest stability to heparin displacement and were associated with the highest transfection efficiencies in two immune cell lines, RAW 264.7 macrophages (77%) and DC2.4 dendritic cells (50%). Transfected DC2.4 cells were shown to be capable of subsequently activating antigen-specific T cells, demonstrating the potential of these multifunctional triblock copolymers for mRNA-based vaccination strategies.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22784603      PMCID: PMC3412061          DOI: 10.1016/j.biomaterials.2012.06.020

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  43 in total

1.  In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies.

Authors:  I Hoerr; R Obst; H G Rammensee; G Jung
Journal:  Eur J Immunol       Date:  2000-01       Impact factor: 5.532

2.  Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells.

Authors:  V F Van Tendeloo; P Ponsaerts; F Lardon; G Nijs; M Lenjou; C Van Broeckhoven; D R Van Bockstaele; Z N Berneman
Journal:  Blood       Date:  2001-07-01       Impact factor: 22.113

3.  Diblock copolymers with tunable pH transitions for gene delivery.

Authors:  Matthew J Manganiello; Connie Cheng; Anthony J Convertine; James D Bryers; Patrick S Stayton
Journal:  Biomaterials       Date:  2011-12-12       Impact factor: 12.479

Review 4.  Prospects for cationic polymers in gene and oligonucleotide therapy against cancer.

Authors:  Thomas Merdan; Jindrich Kopecek; Thomas Kissel
Journal:  Adv Drug Deliv Rev       Date:  2002-09-13       Impact factor: 15.470

5.  Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells.

Authors:  T Bettinger; R C Carlisle; M L Read; M Ogris; L W Seymour
Journal:  Nucleic Acids Res       Date:  2001-09-15       Impact factor: 16.971

6.  Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation.

Authors:  David Oupicky; Manfred Ogris; Kenneth A Howard; Philip R Dash; Karel Ulbrich; Leonard W Seymour
Journal:  Mol Ther       Date:  2002-04       Impact factor: 11.454

Review 7.  Block copolymer micelles for delivery of gene and related compounds.

Authors:  Yoshinori Kakizawa; Kazunori Kataoka
Journal:  Adv Drug Deliv Rev       Date:  2002-02-21       Impact factor: 15.470

8.  Cell-surface glycosaminoglycans inhibit cation-mediated gene transfer.

Authors:  Marika Ruponen; Paavo Honkakoski; Markku Tammi; Arto Urtti
Journal:  J Gene Med       Date:  2004-04       Impact factor: 4.565

Review 9.  Cancer immunotherapy with mRNA-transfected dendritic cells.

Authors:  Eli Gilboa; Johannes Vieweg
Journal:  Immunol Rev       Date:  2004-06       Impact factor: 12.988

10.  Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines.

Authors:  J-P Carralot; J Probst; I Hoerr; B Scheel; R Teufel; G Jung; H-G Rammensee; S Pascolo
Journal:  Cell Mol Life Sci       Date:  2004-09       Impact factor: 9.261

View more
  36 in total

1.  Intracellular delivery system for antibody-Peptide drug conjugates.

Authors:  Geoffrey Y Berguig; Anthony J Convertine; Shani Frayo; Hanna B Kern; Erik Procko; Debashish Roy; Selvi Srinivasan; Daciana H Margineantu; Garrett Booth; Maria Corinna Palanca-Wessels; David Baker; David Hockenbery; Oliver W Press; Patrick S Stayton
Journal:  Mol Ther       Date:  2015-02-11       Impact factor: 11.454

Review 2.  Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.

Authors:  Piotr S Kowalski; Arnab Rudra; Lei Miao; Daniel G Anderson
Journal:  Mol Ther       Date:  2019-02-19       Impact factor: 11.454

Review 3.  Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.

Authors:  S Guan; J Rosenecker
Journal:  Gene Ther       Date:  2017-01-17       Impact factor: 5.250

4.  Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals.

Authors:  Colin J McKinlay; Jessica R Vargas; Timothy R Blake; Jonathan W Hardy; Masamitsu Kanada; Christopher H Contag; Paul A Wender; Robert M Waymouth
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

5.  Enzyme-Cleavable Polymeric Micelles for the Intracellular Delivery of Proapoptotic Peptides.

Authors:  Hanna B Kern; Selvi Srinivasan; Anthony J Convertine; David Hockenbery; Oliver W Press; Patrick S Stayton
Journal:  Mol Pharm       Date:  2017-03-30       Impact factor: 4.939

6.  Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency.

Authors:  Mary G Prieve; Pierrot Harvie; Sean D Monahan; Debashish Roy; Allen G Li; Teri L Blevins; Amber E Paschal; Matt Waldheim; Eric C Bell; Anna Galperin; Jean-Rene Ella-Menye; Michael E Houston
Journal:  Mol Ther       Date:  2018-01-04       Impact factor: 11.454

Review 7.  Nanoscale platforms for messenger RNA delivery.

Authors:  Bin Li; Xinfu Zhang; Yizhou Dong
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2018-05-04

8.  Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivo.

Authors:  Christopher E Nelson; James R Kintzing; Ann Hanna; Joshua M Shannon; Mukesh K Gupta; Craig L Duvall
Journal:  ACS Nano       Date:  2013-09-23       Impact factor: 15.881

9.  Biomaterials for mRNA delivery.

Authors:  Mohammad Ariful Islam; Emma K G Reesor; Yingjie Xu; Harshal R Zope; Bruce R Zetter; Jinjun Shi
Journal:  Biomater Sci       Date:  2015-08-17       Impact factor: 6.843

10.  Injectable Biodegradable Chitosan-Alginate 3D Porous Gel Scaffold for mRNA Vaccine Delivery.

Authors:  Jingxuan Yan; Ruying Chen; Hong Zhang; James D Bryers
Journal:  Macromol Biosci       Date:  2018-11-16       Impact factor: 4.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.